SPIE Acquires Swiss Life Sciences Firm Nimeg AG
European multi-technical services giant SPIE has bought Swiss engineering specialist nimeg ag, boosting its pharma and biotech facilities business.
If you follow the European energy and communications services space, here's a deal worth knowing about. SPIE, the independent European leader in multi-technical services across energy and communications, has officially acquired nimeg ag, a Switzerland-based engineering firm that specializes in the life sciences industry. The deal closed on July 1, 2026.
So what does nimeg ag actually do? Think engineering services tailored specifically for the pharmaceutical and biotechnology sectors — the kind of highly regulated, precision-heavy work that keeps drug manufacturing plants and biotech facilities running smoothly. That's a niche with serious demand, especially as Europe continues expanding its pharmaceutical production capacity.
Read more Surventis Launches as Independent Automotive Coatings Leader →
For SPIE, this acquisition is a strategic two-for-one. First, it deepens the company's footprint in the fast-growing market for pharma and biotech facility services — a segment that's attracting attention from industrial services players across the continent. Second, it extends SPIE's industrial services reach into Switzerland, a country that punches well above its weight in the global life sciences industry, home to giants like Novartis and Roche.
The broader takeaway here is that multi-technical service providers are increasingly chasing the life sciences sector as a growth engine. Pharma and biotech facilities require complex, highly specialized engineering support — from HVAC and cleanroom systems to electrical infrastructure — making them attractive long-term clients for a company like SPIE. Acquiring an established, trusted local player like nimeg ag is a faster path into that market than building from scratch.
Continue reading at GlobalNewswire.
